These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8098905)

  • 1. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.
    O'Sullivan MJ; Boyer PJ; Scott GB; Parks WP; Weller S; Blum MR; Balsley J; Bryson YJ
    Am J Obstet Gynecol; 1993 May; 168(5):1510-6. PubMed ID: 8098905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection.
    Sperling RS; Stratton P; O'Sullivan MJ; Boyer P; Watts DH; Lambert JS; Hammill H; Livingston EG; Gloeb DJ; Minkoff H
    N Engl J Med; 1992 Mar; 326(13):857-61. PubMed ID: 1542322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Chotpitayasunondh T; Vanprapar N; Simonds RJ; Chokephaibulkit K; Waranawat N; Mock P; Stat MA; Chuachoowong R; Young N; Mastro TD; Shaffer N
    Pediatrics; 2001 Jan; 107(1):E5. PubMed ID: 11134469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
    Boucher FD; Modlin JF; Weller S; Ruff A; Mirochnick M; Pelton S; Wilfert C; McKinney R; Crain MJ; Elkins MM
    J Pediatr; 1993 Jan; 122(1):137-44. PubMed ID: 8419601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine pharmacokinetics during pregnancy.
    Sperling RS; Roboz J; Dische R; Silides D; Holzman I; Jew E
    Am J Perinatol; 1992 Jul; 9(4):247-9. PubMed ID: 1627212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental passage of azathiothymidine (AZT) during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound.
    Pons JC; Taburet AM; Singlas E; Delfraissy JF; Papiernik E
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(3):229-31. PubMed ID: 1879598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of pregnant women with human immunodeficiency virus (HIV) infection].
    Figueroa Damián R
    Ginecol Obstet Mex; 1995 May; 63():173. PubMed ID: 7789842
    [No Abstract]   [Full Text] [Related]  

  • 10. Transplacental transfer of zidovudine in the near-term pregnant baboon.
    Hankins GD; Lowery CL; Scott RT; Morrow WR; Carey KD; Leland MM; Colvin EV
    Am J Obstet Gynecol; 1990 Sep; 163(3):728-32. PubMed ID: 2403153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
    Fauchet F; Treluyer JM; Valade E; Benaboud S; Pannier E; Firtion G; Foissac F; Bouazza N; Urien S; Hirt D
    Br J Clin Pharmacol; 2014 Dec; 78(6):1387-96. PubMed ID: 25040510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.
    Cooper ER; Nugent RP; Diaz C; Pitt J; Hanson C; Kalish LA; Mendez H; Zorrilla C; Hershow R; Moye J; Smeriglio V; Fowler MG
    J Infect Dis; 1996 Dec; 174(6):1207-11. PubMed ID: 8940210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine concentrations in human fetal tissue: implications for perinatal AIDS.
    Lyman WD; Tanaka KE; Kress Y; Rashbaum WK; Rubinstein A; Soeiro R
    Lancet; 1990 May; 335(8700):1280-1. PubMed ID: 1971347
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.
    Frenkel LM; Wagner LE; Demeter LM; Dewhurst S; Coombs RW; Murante BL; Reichman RC
    Clin Infect Dis; 1995 May; 20(5):1321-6. PubMed ID: 7620018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
    MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
    Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
    J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the maternal components of the AIDS clinical trial group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1.
    Frenkel LM; Cowles MK; Shapiro DE; Melvin AJ; Watts DH; McLellan C; Mohan K; Murante B; Burchett S; Bryson YJ; O'Sullivan MJ; Mitchell C; Landers D
    J Infect Dis; 1997 Apr; 175(4):971-4. PubMed ID: 9086162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A
    HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and disease progression in human immunodeficiency virus-infected women after an index delivery.
    Gloeb DJ; Lai S; Efantis J; O'Sullivan MJ
    Am J Obstet Gynecol; 1992 Jul; 167(1):152-7. PubMed ID: 1359787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.